Author Correction: Targeted gadofullerene for sensitive magnetic resonance imaging and risk-stratification of breast cancer
In the original version of this Article, the penultimate sentence of the Abstract incorrectly read ‘The dose of the contrast agent for effective molecular MRI is only slightly lower than that of ZD2-Cy5.5 (0.5 µmol kg−1) in fluorescence imaging.’ The correct version states ‘higher’ in place of ‘lowe...
Guardado en:
Autores principales: | Zheng Han, Xiaohui Wu, Sarah Roelle, Chuheng Chen, William P. Schiemann, Zheng-Rong Lu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3442fc02af504e7eb083b1686c88787f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Targeted gadofullerene for sensitive magnetic resonance imaging and risk-stratification of breast cancer
por: Zheng Han, et al.
Publicado: (2017) -
Early stratification of radiotherapy response by activatable inflammation magnetic resonance imaging
por: Zijian Zhou, et al.
Publicado: (2020) -
Ceramic resonators for targeted clinical magnetic resonance imaging of the breast
por: Alena Shchelokova, et al.
Publicado: (2020) -
Author Correction: Compatibility of endoclips in the gastrointestinal tract with magnetic resonance imaging
por: Dong Yeol Shin, et al.
Publicado: (2021) -
Incremental benefit of late gadolinium cardiac magnetic resonance imaging for risk stratification in patients with hypertrophic cardiomyopathy
por: Christina Doesch, et al.
Publicado: (2017)